Skip to the page

Data / Drug companies / Vivunt Pharma LLC

Vivunt Pharma LLC: 31 products in the FDA NDC directory, labeler code 82706

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Vivunt Pharma LLC (labeler code 82706) lists 31 products in the FDA National Drug Code Directory, covering 14 finished drugs by generic name. By type: 31 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 1, 2026.

The request: Watch Vivunt Pharma LLC (FDA labeler code 82706): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
82706
Products in commercial distribution
31
Packages
47
Finished drugs by generic name
14
Prescription products
0
Over the counter products
31
Flagged as original packager
31 of 31 products that carry the flag
Started marketing in the last 12 months
11
Earliest marketing start
May 9, 2022
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs3096.8%
Generic drugs (ANDA)13.2%

Products by type

TypeProductsShare
Over the counter drugs31100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Capsule, liquid filled1238.7%
Liquid619.4%
Tablet516.1%
Kit39.7%
Tablet, chewable26.5%
Aerosol, spray26.5%
Spray13.2%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ibuprofen Minis82706-032Capsule, liquid filledGeneric drugs (ANDA)August 1, 2026
FEVIA Gas Control82706-031Capsule, liquid filledOver the counter monograph drugsFebruary 19, 2026
FEVIA Gas Control82706-031Capsule, liquid filledOver the counter monograph drugsFebruary 19, 2026
FEVIA Constipation Control82706-029Capsule, liquid filledOver the counter monograph drugsFebruary 19, 2026
FEVIA Diarrhea Control82706-028Capsule, liquid filledOver the counter monograph drugsFebruary 18, 2026
FEVIA Diarrhea Control82706-028Capsule, liquid filledOver the counter monograph drugsFebruary 18, 2026
FEVIA Acid Control82706-027Tablet, chewableOver the counter monograph drugsFebruary 18, 2026
FEVIA Acid Control82706-027Tablet, chewableOver the counter monograph drugsFebruary 18, 2026
AXIV Sinus OVERNIGHT82706-034SprayOver the counter monograph drugsJanuary 19, 2026
AXIV Sinus Severe Ultra Fine Mist82706-030Aerosol, sprayOver the counter monograph drugsJanuary 19, 2026
Sinus Severe Ultra Fine Mist82706-026Aerosol, sprayOver the counter monograph drugsJanuary 19, 2026
Sinus Head Congestion82706-025Capsule, liquid filledOver the counter monograph drugsMarch 18, 2025
AXIV Allergy Relief82706-021TabletOver the counter monograph drugsJuly 9, 2024
AXIV DM Max82706-024LiquidOver the counter monograph drugsMay 14, 2024
AXIV Night Time - Liquid82706-023LiquidOver the counter monograph drugsMay 14, 2024
AXIV DayTime - Liquid82706-022LiquidOver the counter monograph drugsMay 14, 2024
AXIV Sinus Severe Mucus82706-020Capsule, liquid filledOver the counter monograph drugsMarch 8, 2024
AXIV Allergy82706-019Capsule, liquid filledOver the counter monograph drugsMarch 8, 2024
AXIV DayTime - NightTime 72 Softgels82706-018KitOver the counter monograph drugsMarch 8, 2024
AXIV DayTime - NightTime 48 Softgels82706-017KitOver the counter monograph drugsMarch 8, 2024
AXIV NightTime82706-016Capsule, liquid filledOver the counter monograph drugsMarch 7, 2024
AXIV DayTime82706-015Capsule, liquid filledOver the counter monograph drugsMarch 7, 2024
AXIV - VroZzz82706-014Capsule, liquid filledOver the counter monograph drugsMarch 7, 2024
AXIM DM Max82706-013LiquidOver the counter monograph drugsJanuary 5, 2024
AXIM Night Time - Liquid82706-012LiquidOver the counter monograph drugsJanuary 5, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.